The role of Artificial Intelligence in diagnosing rare pediatric diseases: A global perspective

*Corresponding author: Venugopal Reddy Iragamreddy. Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. The role of Artificial Intelligence in diagnosing rare pediatric diseases: A global perspective Venugopal Reddy Iragamreddy * Department of Pediatrics, Ovum Woman and Child Speciality Hospital, Bangalore, India. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 036-038 Publication history: Received on 20 November 2024; revised on 28 November 2024; accepted on 31 December 2024 Article DOI: https://doi.org/10.30574/wjbphs.2025.21.1.1108 Abstract Rare pediatric diseases often present significant diagnostic challenges due to their atypical manifestations and lack of familiarity among healthcare providers. Artificial Intelligence (AI) offers transformative potential in bridging diagnostic gaps, particularly in resource-limited settings. This review highlights the role of AI in identifying rare pediatric conditions through advanced algorithms, pattern recognition, and machine learning. By examining successful implementations globally, we explore the potential of AI to revolutionize pediatric diagnostics, address disparities in healthcare access, and improve outcomes for children. Challenges such as data bias, ethical considerations, and infrastructural barriers are also discussed, alongside recommendations for future research and integration strategies. Keywords: Artificial Intelligence; Rare pediatric diseases; Machine learning; Healthcare disparities; Diagnostic tools; Global health 1. Introduction The diagnosis of rare pediatric diseases is a complex process requiring specialized knowledge and significant diagnostic resources. Many healthcare systems, particularly in lowand middle-income countries, lack these resources, leading to delayed or missed diagnoses. The emergence of Artificial Intelligence (AI) as a diagnostic tool has opened new avenues for addressing these challenges. AI’s ability to process vast datasets, recognize patterns, and support clinical decisionmaking holds promise for identifying rare conditions more effectively. This review examines the current role of AI in diagnosing rare pediatric diseases, its global implications, and the potential to mitigate healthcare disparities. 2. Applications of AI in Diagnosing Rare Pediatric Diseases 2.1. Enhanced Diagnostic Accuracy AI-powered tools utilize advanced algorithms to analyze clinical data, imaging, and genetic information, improving diagnostic accuracy for rare conditions. •Machine Learning Algorithms: Predictive models trained on large datasets can identify rare disease patterns often missed by clinicians. •Genomic Sequencing: AI assists in analyzing genomic data to pinpoint mutations associated with rare pediatric diseases such as genetic syndromes or metabolic disorders. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 036-038 37 2.2. Early Detection through Image Analysis AI systems excel in analyzing medical images such as X-rays, MRIs, and CT scans, identifying subtle anomalies that may indicate rare conditions. • Case Study: AI-driven imaging tools have successfully detected early signs of conditions like retinoblastoma and congenital heart defects. • Efficiency: Automated image analysis reduces the time required for diagnosis, enabling earlier intervention. 2.3. Bridging Resource Gaps in Low-Income Settings AI tools have demonstrated the potential to address disparities in healthcare access by supporting diagnostics in resource-constrained environments. • Telemedicine Integration: AI-powered diagnostic platforms enable remote consultations, reducing the dependency on in-person specialist visits. • Low-Cost Diagnostic Solutions: AI tools, such as mobile applications and wearable devices, provide cost-effective options for disease identification in underserved regions. 3. Global Case Studies • AI in Genomics: The Undiagnosed Diseases Network (UDN) uses AI to analyze genomic data, leading to diagnostic breakthroughs for rare diseases. • AI-Powered Diagnostics in Africa: Machine learning platforms in Africa are aiding the diagnosis of pediatric neurological disorders with minimal specialist involvement. • AI in Telemedicine: Initiatives like the AI-powered Babylon Health platform are helping identify rare conditions in remote regions by analyzing patient symptoms. 4. Challenges in AI Integration 4.1. Data Bias and Generalizability AI models often rely on datasets that lack diversity, leading to potential biases in diagnostic predictions. 4.2. Ethical and Privacy Concerns The use of patient data in AI systems raises concerns about confidentiality, consent, and potential misuse of sensitive information. 4.3. Infrastructural Barriers Limited access to advanced technology, inconsistent internet connectivity, and inadequate training for healthcare providers hinder AI adoption in resource-limited settings. 5. Future Directions 5.1. Collaborative Research and Data Sharing • Establish global databases to improve AI model training and reduce bias. • Foster collaborations between high-income and low-income countries to promote equitable access to AI tools. 5.2. Ethical Frameworks and Regulation • Develop comprehensive guidelines to ensure ethical use of AI in pediatric diagnostics. • Promote transparency and accountability in AI-driven decision-making. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 036-038 38 5.3. Capacity Building • Train healthcare professionals in AI tools to enhance their diagnostic capabilities. • Invest in technological infrastructure to support AI integration in underserved regions. 6. Conclusion Artificial Intelligence has the potential to revolutionize the diagnosis of rare pediatric diseases by enhancing accuracy, reducing diagnostic timelines, and addressing healthcare inequities. However, its successful implementation requires overcoming challenges related to data bias, ethical concerns, and infrastructural limitations. By fostering global collaboration, investing in equitable healthcare strategies, and promoting ethical AI practices, we can harness the transformative power of AI to improve outcomes for children with rare diseases worldwide. Compliance with ethical standards Acknowledgments The author extends gratitude to the global healthcare and AI communities for their advancements in pediatric diagnostics and their dedication to equitable healthcare. Disclosure of conflict of interest The author declares no conflict of interest. References [1] Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine. 2019;25(1):44-56. [2] Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319(13):1317-18. [3] Li Q, et al. Artificial intelligence in rare disease diagnosis. Frontiers in Medicine. 2020; 7:599. [4] Holzinger A, et al. Machine learning for health care and precision medicine. Annual Review of Biomedical Data Science. 2019;2(1):447-85. [5] Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncology. 2019;20(5):e262-73. Author’s short Biography Dr. Venugopal Reddy is a distinguished Medical Director and Pediatrician at Ovum woman and Child Speciality Hospital in Bangalore, India. With extensive expertise in pediatric care, research, and community health initiatives, he has authored nearly 100 articles in Scopus and PubMed-indexed journals. He is actively involved in improving healthcare systems, child health awareness, and maternal well-being. His work has earned him recognition as one of the top professionals shaping healthcare in India.